Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets

M Nimgampalle, V Devanathan… - Journal of Biomolecular …, 2021 - Taylor & Francis
Recently Chloroquine and its derivative Hydroxychloroquine have garnered enormous
interest amongst the clinicians and health authorities' world over as a potential treatment to …

In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2

S Beura, P Chetti - Journal of Biomolecular Structure and …, 2021 - Taylor & Francis
The global health emergency of novel COVID-19 is due to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). Currently there are no approved drugs for the …

Computational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2

D Patel, M Athar, PC Jha - Journal of Biomolecular Structure and …, 2022 - Taylor & Francis
Novel coronavirus SARS-CoV-2 has infected 18 million people with 700,000+ mortalities
worldwide and this deadly numeric figure is rapidly rising. With very few success stories, the …

Docking study of chloroquine and hydroxychloroquine interaction with RNA binding domain of nucleocapsid phospho-protein – an in silico insight into the …

M Amin, G Abbas - Journal of Biomolecular Structure and …, 2021 - Taylor & Francis
Recent outbreak of novel Coronavirus disease () pandemic around the world is associated
with severe acute respiratory syndrome. The death toll associated with the pandemic is …

Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study

I Celı̇k, A Onay-Besı̇kcı̇… - Journal of Biomolecular …, 2021 - Taylor & Francis
We aimed to analyze the interactions of both hydroxychloroquine and chloroquine with
SARS-CoV-2 and identify their possible role for the prevention/treatment of COVID-19 by …

In silico insight into the interaction of 4-aminoquinolines with selected SARS-CoV-2 structural and nonstructural proteins

H Tijjani, A Olatunde, AP Adegunloye… - Coronavirus Drug …, 2022 - Elsevier
The development of efficacious therapeutic agents with relatively low or no level of toxicity
was necessitated due to the reemergence of coronavirus. The present study investigated the …

[PDF][PDF] The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2

RR Narkhede, RS Cheke, JP Ambhore… - Eurasian Journal of …, 2020 - academia.edu
Objectives: The novel human coronavirus designated severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) first emerged in late 2019 in Wuhan, China. This virus spread …

Discovery of potential SARS-CoV 3CL protease inhibitors from approved antiviral drugs using: virtual screening, molecular docking, pharmacophore mapping …

I Daoud, F Mesli, N Melkemi, S Ghalem… - Journal of Biomolecular …, 2022 - Taylor & Francis
The spread of corona-virus disease 2019 (COVID-19) has been faster than any other corona-
viruses that have succeeded in crossing the animal-human barrier. This disease, caused by …

In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection

HLB Braz, JA de Moraes Silveira, AD Marinho… - International journal of …, 2020 - Elsevier
ABSTRACT Coronavirus disease 2019 (COVID-19) is a highly transmissible viral infection
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical trials …

Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19 …

D Mishra, RR Maurya, K Kumar, NS Munjal… - Journal of Molecular …, 2021 - Elsevier
Now a days, more than 200 countries faces the health crisis due to epidemiological disease
COVID-19 caused by SARS-CoV-2 virus. It will cause a very high impact on world's …